Does Melanoma Itch or Hurt? Sensory Symptoms Explained

Melanoma can itch, and less often it can hurt, but most melanomas produce no sensation at all. In studies comparing skin cancers, only about 15 percent of melanomas were associated with itch and fewer than 4 percent with pain, making sensory symptoms far less reliable as warning signs than visible changes in a mole’s shape, color, or size. That does not mean you should ignore a mole that itches or stings. It means the absence of discomfort should never be taken as reassurance that a spot is harmless.

How Common Itch and Pain Actually Are

The most useful numbers on this come from a study published in JAMA Dermatology that compared sensory symptoms across the three major skin cancers: melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC). Of the melanomas studied, about 15 percent were itchy and roughly 4 percent were painful. Those figures are strikingly low compared to the other two cancers. SCC led the pack, with nearly 47 percent of cases itchy and about 43 percent painful. BCC fell in the middle, with about 32 percent itchy and 20 percent painful.¹

The practical takeaway is straightforward: if you are waiting for a mole to itch or hurt before getting it checked, you will miss the vast majority of melanomas. Most melanomas grow silently for weeks or months, changing visually without producing any physical sensation you can feel. The classic screening approach focuses on what a lesion looks like, and for good reason. Sensory symptoms are a bonus clue when they show up, not a reliable gatekeeper.

Itch as an Early Warning Sign

Even though itch is uncommon in melanoma overall, when it does occur it can serve as the thing that finally gets a person to look more closely at a spot they had been ignoring. In one study of delays in melanoma diagnosis, about 16 percent of patients reported being aware of an altered sensation, specifically itch, related to the lesion that was eventually diagnosed as melanoma.² That is a meaningful minority. For those patients, the itch was a prompt to seek medical attention, even if most of their fellow melanoma patients never felt anything.

Interestingly, that same study found no difference in how long patients waited to see a doctor between those who noticed visual changes (size, shape, color) and those who noticed more alarming physical symptoms like bleeding or elevation. You might expect someone with a bleeding mole to rush to a clinic faster than someone whose mole just looked a little different, but the data did not support that. Delay was similar across symptom types, which suggests that the decision to seek help depends more on personal vigilance and access to care than on which specific symptom appeared.²

So while itch is not a defining feature of melanoma, it still plays a role in real-world detection. If a mole starts itching and you have not changed soaps, detergents, or anything else that could explain the irritation, that is worth investigating, especially if the mole has also changed in appearance.

How Melanoma Subtype Affects Symptoms

Not all melanomas behave the same way, and the subtype matters when thinking about sensory symptoms. The two most common subtypes people encounter are superficial spreading melanoma (SSM), which grows outward across the skin surface before diving deeper, and nodular melanoma (NM), which grows downward more aggressively from the start. Qualitative research with patients found that those with thin nodular melanoma reported fewer physical symptoms like itching, bleeding, irritation, or pain in the year before diagnosis compared to patients with superficial spreading melanoma at similar or greater thickness.³

This is a problem because nodular melanoma is the more dangerous subtype in terms of how quickly it can become life-threatening. It tends to present as a raised bump, sometimes pink or red rather than the dark brown or black people associate with melanoma. The fact that it often lacks itch or other sensory cues in its early stages makes it easier to dismiss as a pimple, insect bite, or minor irritation. Patients with thin SSM, by contrast, were more likely to describe their mole as “really itchy” or otherwise physically noticeable, which may have prompted earlier visits to a doctor.³

The lesson here cuts against intuition. The melanomas most likely to produce itch tend to be the ones caught at a thinner, more treatable stage. The ones that grow fast and deep often give fewer sensory warnings. Relying on symptoms to tell you when to worry is risky precisely because the most dangerous melanomas are the quietest.

Why Melanoma Can Produce Sensations at All

It might seem odd that a skin growth could itch or hurt before it becomes large or ulcerated. Part of the explanation lies in the biology of the cells involved. Melanocytes, the pigment-producing cells that give rise to melanoma, share an embryological origin with certain nerve cells. Both come from the neural crest, a structure that forms early in fetal development and sends cells off to become skin pigment cells, nerve-supporting cells, and other tissue types.⁴ Because of this shared lineage, melanoma cells can interact with nerve fibers in the skin in ways that other cancers typically do not.

Additionally, the immune system’s response to a growing tumor plays a role. When immune cells infiltrate a melanoma, they release signaling molecules that can activate nearby sensory nerve endings. The same JAMA Dermatology study that measured itch and pain rates also examined the inflammatory cell makeup of these tumors, exploring the connection between immune activity around a lesion and the sensory symptoms a patient reports.¹ In simpler terms, the body’s attempt to fight the cancer sometimes produces the itch or tenderness a patient notices.

This helps explain why itch tends to be more common in early-stage melanomas with an active immune response at the surface, and why deeper or faster-growing tumors may not trigger the same sensation. The tumor’s relationship with the local immune environment is what creates or suppresses the sensory experience.

When the Symptom Comes From Treatment, Not the Tumor

If you or someone you know has been diagnosed with melanoma and starts experiencing intense itching or skin rashes during treatment, it is important to understand that these symptoms often come from the therapy itself rather than the cancer. Modern melanoma treatment frequently involves immunotherapy drugs called checkpoint inhibitors. These medications work by releasing the brakes on the immune system so it can attack cancer cells more effectively. A predictable side effect is that the revved-up immune system also attacks healthy tissue, including the skin.

Skin reactions are among the most common side effects of checkpoint inhibitors. Patients treated with one class of these drugs experience skin-related immune side effects roughly 43 to 45 percent of the time, while another class produces them in about 34 percent of patients.⁵ These reactions typically appear within the first two to eight weeks after starting treatment.

The most common form is a rash made up of red, slightly raised patches that tend to appear on the trunk and outer surfaces of the arms and legs. These patches are usually itchy and can flare after each treatment cycle.⁵ Another common reaction produces violet, scaly, itchy plaques that can appear months into treatment and tend to be associated with a different class of checkpoint inhibitors.⁵

The confusion this creates is understandable. A melanoma patient who never had itchy skin before starting treatment and then develops widespread itching may worry the cancer is spreading. In most cases, what they are actually experiencing is their immune system doing exactly what the drugs are designed to make it do, just a little too enthusiastically. The treatment team will typically manage these side effects with topical creams or, in more severe cases, brief pauses in treatment. Knowing that treatment-related itch is common and expected can reduce a lot of unnecessary anxiety.

Pain and Daily Life in Advanced Melanoma

While early melanoma rarely hurts, the picture changes as the disease advances. Melanoma that has spread to lymph nodes, bones, the brain, or internal organs can produce significant pain. This is not unique to melanoma; most cancers that metastasize can cause pain depending on where they land. Bone metastases tend to produce deep, aching pain. Brain metastases may cause headaches. Skin metastases can become tender or ulcerated.

Research into quality of life for patients with advanced melanoma treated with immunotherapy found that pain at baseline was significantly linked to survival outcomes. In a study of patients with advanced melanoma receiving treatment, those who reported worse pain, fatigue, and appetite loss before starting therapy had shorter survival times, even after adjusting for other prognostic factors.⁶ This does not mean pain causes worse outcomes. Rather, it reflects the fact that patients who are already feeling significant symptoms tend to have more advanced or aggressive disease.

For patients and families, the important point is that pain in advanced melanoma is real, can be substantial, and should be treated aggressively with palliative care. It is not something to power through. Modern pain management, including medications, nerve blocks, and radiation to painful metastatic sites, can significantly improve comfort and function. If a melanoma patient is experiencing new or worsening pain, that is always worth reporting to the care team, both for symptom management and because it may signal a change in the disease.

What the ABCDE Checklist Does Not Tell You About Sensations

Most people who have heard anything about melanoma detection know the ABCDE checklist: Asymmetry, Border irregularity, Color variation, Diameter over six millimeters, and Evolution (change over time). This framework is entirely visual. It says nothing about how a mole feels, and that is by design. The checklist was built around the features most consistently associated with melanoma, and sensory symptoms did not make the cut because they are too inconsistent.

Some expanded screening tools have added sensory clues. The seven-point checklist used in some clinical settings, for instance, includes “change in sensation” as one of its minor criteria. But even in that framework, sensation is a supporting factor, not a major one. A mole that itches but looks perfectly normal and has not changed would not score high enough to warrant urgent referral under most structured screening systems.

This is where people sometimes get misled by well-meaning advice. You might read online that “melanoma itches” as if itching is a hallmark symptom. It is not. It is a minority finding. The worry should go the other direction: most melanomas do not itch, so do not let a painless, non-itchy mole lull you into thinking it is safe. The visual features, especially change over time, remain far more reliable indicators.

When Melanoma Looks Different From the Textbook

The sensory-symptom question ties into a broader challenge with melanoma detection: the disease does not always look the way people expect. A multicenter study of pediatric melanoma illustrates this well. While the conventional ABCDE criteria picked up melanoma features in most young patients (about 69 percent had asymmetric lesions, 64 percent had irregular edges, 59 percent showed two or more colors), a modified set of criteria designed for pediatric cases performed worse. Features like amelanotic (non-pigmented) appearance, raised nodular shape, and uniform color were rare, appearing in only about 5 to 10 percent of pediatric melanomas.⁷

The relevance to sensory symptoms is this: if melanoma can fool the eye by lacking the expected visual features, it can certainly fool the body by lacking the expected physical sensations. Amelanotic melanomas, which appear pink, red, or skin-colored rather than dark, are among the most frequently missed because they do not match what patients or even some clinicians are looking for. These lesions are also less likely to produce the immune response that triggers itch, making them doubly stealthy.

For adults, the same principle holds. If you have a spot that is growing, changing shape, or developing uneven color, the fact that it does not itch or hurt should carry zero weight in your decision to get it checked. Roughly 85 percent of melanomas will never itch, and more than 96 percent will never hurt, based on the data from the JAMA Dermatology study discussed earlier.¹ Waiting for a physical symptom to appear before acting is one of the most common and most dangerous misconceptions about this cancer.

Other Skin Conditions That Mimic Melanoma Symptoms

One reason the “does melanoma itch” question comes up so often is that people notice an itchy mole and immediately worry. In most cases, the itch has nothing to do with cancer. Moles can itch because of friction from clothing, dryness, minor irritation from shaving, or inflammatory skin conditions like eczema that happen to overlap with a mole’s location. A mole on your waistband or bra line may become intermittently irritated for years without anything sinister going on.

Seborrheic keratoses, those waxy, stuck-on-looking growths that become more common with age, are particularly good at mimicking melanoma fears. They can be dark, irregularly shaped, and itchy. They are also completely benign. Dermatofibromas, small firm bumps on the legs, can itch and sometimes darken in color, prompting melanoma worries. Even insect bites or minor allergic reactions near an existing mole can create a temporary sensation that feels alarming.

The key distinction is not whether a mole itches but whether it is changing. A mole that has looked the same for ten years and suddenly starts itching probably deserves a look from a dermatologist, not because the itch itself is suspicious, but because it gives you a reason to get a professional baseline evaluation. A mole that is itching and visibly evolving, growing, darkening, losing its symmetry, or developing an uneven border, is the combination that warrants urgency. The itch alone is not the alarm. The itch plus visual change is.

If you do have a mole evaluated and the dermatologist says it looks fine, the itch is overwhelmingly likely to be caused by something mundane. Dry skin, friction, and minor inflammation account for the vast majority of itchy moles. The peace of mind from having it checked, though, is worth the visit, especially if you have risk factors like fair skin, a history of sunburns, or a family history of melanoma.